Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
The new ECO grade is made using renewable feedstock
The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana
Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December
Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US
The product has been in-licensed from Strides and will be commercialized by Amneal
Currently, Venkat is Lead – Market Access, India at Pfizer
The product is expected to be launched in FY25
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Subscribe To Our Newsletter & Stay Updated